---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-014254"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T05:46:06.799298+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q3 revenue up 5% to $73.1M; guides FY2024 $292-295M, authorizes $30M buyback

## Summary
- Q3 revenue $73.1M (+5% YoY); lymphedema +4%, airway clearance +10%.
- Net income $5.2M ($0.21 diluted) vs $22.3M in Q3 2023; adjusted EBITDA $10.7M vs $7.7M.
- Gross margin improved to 75.0% from 70.9%; operating expenses up 16%.
- FY2024 revenue guidance narrowed to $292-295M (prior $293-298M; growth 6-8%).
- Board authorized up to $30M share repurchase program through Oct 31, 2026.

## SEC filing metadata
- accession: 0001558370-24-014254
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837024014254/0001558370-24-014254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837024014254/tcmd-20241104x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-014254
- JSON: https://secwatch.observer/filing/0001558370-24-014254.json
- Plain text: https://secwatch.observer/filing/0001558370-24-014254.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.